These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19577615)

  • 1. bFGF induces changes in hyaluronan synthase and hyaluronidase isoform expression and modulates the migration capacity of fibrosarcoma cells.
    Berdiaki A; Nikitovic D; Tsatsakis A; Katonis P; Karamanos NK; Tzanakakis GN
    Biochim Biophys Acta; 2009 Oct; 1790(10):1258-65. PubMed ID: 19577615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of hyaluronan and versican deposition by growth factors in fibrosarcoma cell lines.
    Berdiaki A; Zafiropoulos A; Fthenou E; Katonis P; Tsatsakis A; Karamanos NK; Tzanakakis GN
    Biochim Biophys Acta; 2008 Feb; 1780(2):194-202. PubMed ID: 17980161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid hormone (PTH) peptides through the regulation of hyaluronan metabolism affect osteosarcoma cell migration.
    Berdiaki A; Datsis GA; Nikitovic D; Tsatsakis A; Katonis P; Karamanos NK; Tzanakakis GN
    IUBMB Life; 2010 May; 62(5):377-86. PubMed ID: 20222016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronan stimulates pancreatic cancer cell motility.
    Cheng XB; Kohi S; Koga A; Hirata K; Sato N
    Oncotarget; 2016 Jan; 7(4):4829-40. PubMed ID: 26684359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of receptor for hyaluronic acid-mediated motility (RHAMM) in low molecular weight hyaluronan (LMWHA)-mediated fibrosarcoma cell adhesion.
    Kouvidi K; Berdiaki A; Nikitovic D; Katonis P; Afratis N; Hascall VC; Karamanos NK; Tzanakakis GN
    J Biol Chem; 2011 Nov; 286(44):38509-38520. PubMed ID: 21914806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor for hyaluronic acid- mediated motility (RHAMM) regulates HT1080 fibrosarcoma cell proliferation via a β-catenin/c-myc signaling axis.
    Kouvidi K; Berdiaki A; Tzardi M; Karousou E; Passi A; Nikitovic D; Tzanakakis GN
    Biochim Biophys Acta; 2016 Apr; 1860(4):814-24. PubMed ID: 26825774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration.
    Kung CI; Chen CY; Yang CC; Lin CY; Chen TH; Wang HS
    Oncol Rep; 2012 Nov; 28(5):1808-14. PubMed ID: 22922740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer.
    Udabage L; Brownlee GR; Nilsson SK; Brown TJ
    Exp Cell Res; 2005 Oct; 310(1):205-17. PubMed ID: 16125700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor-2 stimulates directed migration of periodontal ligament cells via PI3K/AKT signaling and CD44/hyaluronan interaction.
    Shimabukuro Y; Terashima H; Takedachi M; Maeda K; Nakamura T; Sawada K; Kobashi M; Awata T; Oohara H; Kawahara T; Iwayama T; Hashikawa T; Yanagita M; Yamada S; Murakami S
    J Cell Physiol; 2011 Mar; 226(3):809-21. PubMed ID: 20857427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragmented hyaluronan is an autocrine chemokinetic motility factor supported by the HAS2-HYAL2/CD44 system on the plasma membrane.
    Saito T; Kawana H; Azuma K; Toyoda A; Fujita H; Kitagawa M; Harigaya K
    Int J Oncol; 2011 Nov; 39(5):1311-20. PubMed ID: 21743962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HAS3-related hyaluronan enhances biological activities necessary for metastasis of osteosarcoma cells.
    Tofuku K; Yokouchi M; Murayama T; Minami S; Komiya S
    Int J Oncol; 2006 Jul; 29(1):175-83. PubMed ID: 16773198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44.
    Golshani R; Lopez L; Estrella V; Kramer M; Iida N; Lokeshwar VB
    Cancer Res; 2008 Jan; 68(2):483-91. PubMed ID: 18199543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RHAMM/hyaluronan inhibit β-catenin degradation, enhance downstream signaling, and facilitate fibrosarcoma cell growth.
    Berdiaki A; Thrapsanioti LN; Giatagana EM; K Karamanos N; C Savani R; N Tzanakakis G; Nikitovic D
    Mol Biol Rep; 2023 Nov; 50(11):8937-8947. PubMed ID: 37710072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated level of ambient glucose stimulates the synthesis of high-molecular-weight hyaluronic acid by human mesangial cells. The involvement of transforming growth factor beta1 and its activation by thrombospondin-1.
    Yevdokimova NY
    Acta Biochim Pol; 2006; 53(2):383-93. PubMed ID: 16733556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells.
    Li Y; Li L; Brown TJ; Heldin P
    Int J Cancer; 2007 Jun; 120(12):2557-67. PubMed ID: 17315194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix.
    Zhu H; Mitsuhashi N; Klein A; Barsky LW; Weinberg K; Barr ML; Demetriou A; Wu GD
    Stem Cells; 2006 Apr; 24(4):928-35. PubMed ID: 16306150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer stem-like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production.
    Hiraga T; Ito S; Nakamura H
    Cancer Res; 2013 Jul; 73(13):4112-22. PubMed ID: 23633482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells.
    Li L; Qi L; Liang Z; Song W; Liu Y; Wang Y; Sun B; Zhang B; Cao W
    Int J Mol Med; 2015 Jul; 36(1):113-22. PubMed ID: 26005723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells.
    Funasaka T; Hu H; Yanagawa T; Hogan V; Raz A
    Cancer Res; 2007 May; 67(9):4236-43. PubMed ID: 17483335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronan/RHAMM interactions in mesenchymal tumor pathogenesis: role of growth factors.
    Kouvidi K; Nikitovic D; Berdiaki A; Tzanakakis GN
    Adv Cancer Res; 2014; 123():319-49. PubMed ID: 25081535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.